Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.

Although no notable change was observed in the total mBC population (data not shown), there was a decreasing trend in CD38 + switched mBCs (Figure 4 C, P = 0.069) and an increase in CD38 − mBCs (Figure 4 D, P = 0.006 and adjusted P value = 0.069).

also in 47,180 other papers